Patent annuity fees by country vary less in amount than in structure, and the structure is what drives the cost.
The US charges three times, after grant. Everywhere else, broadly, charges every year — and frequently starts before grant.
That difference compounds. A US patent has three renewal decisions across its life. A four-country family can have sixty or more.
Which is why foreign portfolios get pruned first, almost always.
The structural difference
| United States | Most other jurisdictions | |
|---|---|---|
| Frequency | 3 payments | Annual |
| Starts | After grant | Often during pendency |
| Escalation | Three steps | Every year |
| Decisions per patent | 3 | Up to 20 |
| Entity discounts | Small 40%, micro 20% | Varies; different criteria |
| Grace period | 6 months + surcharge | Commonly 6 months + surcharge |
Payable during pendency is the part people miss. Cost begins accruing in many countries years before any enforceable right exists.
US maintenance fees
| Fee | Due after grant | Large | Small (40%) | Micro (20%) |
|---|---|---|---|---|
| First | 3.5 years | $2,150 | $860 | $430 |
| Second | 7.5 years | $4,040 | $1,616 | $808 |
| Third | 11.5 years | $8,280 | $3,312 | $1,656 |
| Total | $14,470 | $5,788 | $2,894 |
Nothing is due while pending, and nothing is due in the first three years after grant.
Entity status must be true at each payment, not just at filing. Growth past 500 employees or a licence to a large entity ends small entity eligibility. See small entity status.
Europe after grant
| Stage | What happens |
|---|---|
| EPO application | Annuities payable to the EPO from year 3 |
| Grant | — |
| Validation | Per designated state |
| After validation | National annuities in each state |
| Consequence | One patent becomes several renewal obligations |
A European patent fragments at grant. Validating in five states creates five national rights with five annuity streams and five sets of consequences for missing one.
Which is why validation choices matter more than filing choices. The EPO route defers the decision; validation is where the ongoing cost is committed.
What drives the total
| Driver | Effect |
|---|---|
| Number of jurisdictions | Largest driver |
| Years held | Annuities escalate |
| Pendency length | Where annuities accrue during it |
| Local agent requirements | Adds fees per payment |
| Currency conversion margins | On every foreign payment |
| Entity status | Where discounts exist |
Country count dominates everything else. Doubling jurisdictions roughly doubles the deadline volume and the administrative load, before any fee is paid.
Conversion margins are real money. They apply to every foreign payment and are easy to overlook when comparing service quotes. See patent annuity payment services.
Deadline volume
| Portfolio | Approximate annual deadlines |
|---|---|
| 10 US patents | ~3 per year on average |
| 10 US + 10 EP validations | ~13 |
| 10 patents × 4 jurisdictions | ~30 |
| 50 patents × 4 jurisdictions | ~150 |
Manual tracking fails somewhere in the second row. The failure is not gradual — one missed annuity ends a patent in that jurisdiction, usually without recovery.
This is the practical argument for a service, and it is about volume rather than complexity.
Worked example: one family, four countries
A small entity files in 2018, grants in the US in 2022.
| Jurisdiction | Structure | Deadlines over 20 years |
|---|---|---|
| United States | 3 fees after grant | 3 |
| Europe (3 validated states) | Annual, per state | ~45 |
| China | Annual | ~17 |
| Japan | Annual | ~17 |
| Total | ~82 |
Where the decisions fall
| Year | Decision |
|---|---|
| 2021 | EPO annuities during pendency — pay or abandon |
| 2023 | Validation choices — commits ongoing cost per state |
| 2024 | First foreign pruning — one EP state dropped |
| 2026 | US first maintenance fee, $860 |
| 2028 | Japan annuity escalating — reviewed |
| 2030 | US second fee, $1,616 |
| 2034 | US third fee, $3,312 — the largest single decision |
The foreign pruning happened ten years before the US one. That ordering is typical, because annual escalating costs force the question sooner than a three-step schedule does.
The US third fee is still the largest single payment, arriving last.
What the US data shows
| Ipiry Patent Survival Curve v1.0 | Rate |
|---|---|
| Survive the 3.5-year fee (2022 cohort) | 85.8% |
| Survive the 7.5-year fee (2018 cohort) | 64.6% |
| Reach full term (2014 cohort) | 41.4% |
| Abandoned before full term | 58.6% |
| Lost at the third fee | 23.2 points |
| Conditional: paid first two, pay third | 63.0% |
Computed from 27,273,654 USPTO maintenance fee records covering 8,262,336 US utility patents — see the patent survival curve.
That is the domestic attrition rate with only three decisions. Foreign members face the question annually, and attrition abroad is correspondingly earlier.
Design and plant patents
| Utility | Design (US) | Design (EU/UK) | |
|---|---|---|---|
| Renewal | 3 fees | None | Every 5 years |
| Term | 20 yrs from filing | 15 yrs from grant | Up to 25 years |
| Attrition | 58.6% abandoned | Almost none | Renewal-driven |
US design patents require nothing after grant, which is unusual internationally. Registered designs in Europe, the UK, Japan and China all require renewal. See how long are design patents good for.
Where costs accumulate
| Year of holding | Typical pattern |
|---|---|
| Years 1–5 | Modest annuities, sometimes during pendency |
| Years 6–10 | Rising steadily |
| Years 11–20 | Substantially higher each year |
| US | Three steps instead of a curve |
Foreign annuities rise every year; US fees rise three times. That difference is why foreign members are pruned earlier — the question is asked annually rather than triennially.
Model the full curve before validating widely. Validation in five states commits five escalating streams for up to twenty years.
Verify amounts at source
| Fees change | Regularly |
| Set in | Local currency |
| Aggregated tables | Go stale |
| Authoritative source | Each national office |
| Before budgeting | Verify directly |
Treat any published fee table as indicative. Amounts, entity criteria and schedules all change, and a budget built on a two-year-old comparison will be wrong.
Recorded ownership blocks payments
| Jurisdiction requirement | Effect |
|---|---|
| Recorded owner must match | Several jurisdictions |
| Unrecorded assignment | Can block a renewal payment |
| Corporate name change unrecorded | Same |
| Consequence | Missed annuity, patent lost |
An unrecorded foreign transfer becomes a missed deadline. Record assignments in every jurisdiction where rights exist, promptly. See assignment search.
Deciding what to keep
| Question | Per jurisdiction |
|---|---|
| Do we sell there? | Revenue justifies cost |
| Do competitors manufacture there? | Supply-chain leverage |
| Is the market growing or shrinking? | Forward view |
| Would we enforce there? | Practical reality |
| What is the escalating cost curve? | Later years cost more |
Each jurisdiction is an independent annual decision. Holding a country because it was filed once is how portfolios accumulate cost without accumulating value.
Start any sale months ahead of a deadline. A patent sold before a grace period closes is worth something; the same patent afterwards is worth nothing. See patent portfolio management.
Patent annuity fees by country: the checklist
- Understand the structure before the amounts. Annual versus three-step drives everything.
- Check which jurisdictions charge during pendency. Cost starts before rights do.
- Treat European validation as the real commitment, not the EPO filing.
- Count deadlines, not patents. Volume is what breaks manual tracking.
- Verify entity discounts per jurisdiction. US criteria do not carry across.
- Include currency conversion margins when comparing service costs.
- Pay before the grace period, not during it.
- Use an annuity service for any foreign portfolio.
- Verify current fees at each national office before budgeting.
- Review each jurisdiction annually against revenue and manufacturing.